Cefpodoxime

100 mg/5 mL, 50 mL bottle, 1 count (NDC 65862-0141-50) - discontinued
100 mg/5 mL, 100 mL bottle, 1 count (NDC 65862-0141-01) - discontinued

 

Cefpodoxime oral suspension, Sandoz
50 mg/5 mL, 50 mL bottle, 1 count (NDC 00781-6168-52) - discontinued
50 mg/5 mL, 100 mL bottle, 1 count (NDC 00781-6168-46) - discontinued
100 mg/5 mL, 50 mL bottle, 1 count (NDC 00781-6169-52) - discontinued

Reason for the Shortage

• Aurobindo discontinued cefpodoxime oral suspension.
• Pfizer has discontinued Vantin.
• Ranbaxy has an import ban on all solid medications including cefpodoxime.
• Sandoz could not provide a reason for the shortage. They have discontinued 50 mg/mL 50 mL and 100 mL oral suspension and 100 mg/mL 50 mL oral suspension.

Available Products

Cefpodoxime oral tablet, Aurobindo
100 mg, 20 count (NDC 65862-0095-20)

200 mg, 20 count (NDC 65862-0096-20)

 

Cefpodoxime oral suspension, Sandoz
100 mg/5 mL, 50 mL bottle, 1 count (NDC 00781-6169-52) - discontinued

100 mg/5 mL, 100 mL bottle, 1 count (NDC 00781-6169-46)

 

Cefpodoxime oral tablet, Sandoz
100 mg, 20 count (NDC 00781-5438-20)

200 mg, 20 count (NDC 00781-5439-20)

200 mg, 100 count (NDC 00781-5439-01)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages

• Amikacin Injection — Current
• Avibactam/Ceftazidime Injection — Current
• Azithromycin Injection — Resolved
• Aztreonam Injection — Resolved
• Cefaclor Suspension — Resolved
• Cefazolin Injection — Resolved
• Cefotaxime Injection — No Commercially Available Preparations
• Ceftazidime Injection — Current
• Cefuroxime Sodium Injection — Resolved
• Ciprofloxacin Immediate-Release Tablets — Resolved
• Ciprofloxacin Injection — Resolved
• Clarithromycin Immediate-Release Tablets — Resolved
• Clindamycin Injection — Current
• Doxycycline Capsules and Tablets — Resolved
• Doxycycline Hyclate Injection — Resolved — No Commercially Available Preparations
• Erythromycin Lactobionate Injection — No Commercially Available Preparations
• Erythromycin Oral Products — Resolved
• Erythromycin Oral Products (Abbott Brand Only) — Resolved
• Gentamicin injection — Current
• Kanamycin Sulfate Injection — No Longer Available
• Levofloxacin Injection — Resolved
• Meropenem Injection — Resolved
• Mupirocin Calcium 2% Cream — Current
• Mupirocin Calcium 2% Nasal Ointment — No Commercially Available Preparations
• Polymyxin B Sulfate Injection — Resolved
• Streptomycin Injection — Resolved
• Sulfamethoxazole/Trimethoprim Injection — Resolved
• Telavancin Injection — Resolved
• Tetracycline Capsules — Resolved
• Vancomycin Hydrochloride Injection — Current

Updated

September 27, July 15, April 18, January 25, 2016; December 3, October 19, September 9, June 29 and 9, March 23, January 28, 2015; December 10, October 20, September 10, August 27 and 7, July 15, June 3, April 24, March 20 and 3, February 10, 2014; December 4, November 21 and 5, October 2, September 16, August 23, July 25, May 28 and 6, April 23 and 2, March 1, January 28, 2013; November 9, September 27, July 6, May 15, March 22, 2012; December 8, October 5, August 24, July 29, June 24, May 20, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.